Department of Gastroenterological Surgery, Toranomon Hospital, and Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Department of Gastroenterology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Esophagus. 2022 Jan;19(1):85-94. doi: 10.1007/s10388-021-00868-4. Epub 2021 Jul 31.
There has been much debate on whether to perform TD resection in radical esophagectomy for esophageal cancer from the perspectives of metastatic rate, effect on postoperative hemodynamics, and other factors. The objective of this study was to determine whether TDLN dissection contributes to improved prognosis.
This study involved 1211 patients who underwent D2/D3 dissection with TD resection for thoracic esophageal cancer between 1984 and 2020. The lymph nodes along the TD were defined as TDLNs and the remaining No. 112 nodes as non-TDLNs. The metastatic rate in TDLNs and non-TDLNs and their outcomes were compared with those of other thoracic lymph nodes. Correlation with the invasion depth of the main lesion was also analyzed (T0-2 545 patients, T3-4 666 patients).
The metastatic rates in TDLNs/non-TDLNs in all patients were 7.3%/7.5%, respectively, while those in T0-2 were 2.2%/3.9%, and those in T3-4 were 11.5%/10.6%, with both having higher rates in advanced cases. The efficacy index (EI) for lymphadenectomy in T3-4 was 2.94 for TDLNs and 3.44 for non-TDLNs, with no significant difference. The metastatic rate in TDLNs by tumor site was as follows: Ut/Mt/Lt = 1.1/2.4/2.4% (T0-2) and 7.7/14.5/8.4% (T3-4), being especially high (~ 15%) in patients with advanced cases in Mt region. The EI was comparable or higher for TDLNs compared with other group-2 (Mt/Lt) and group-3 (Ut) regional lymph nodes, regardless of site.
The significance of TD resection was low in T0-2 due to the low metastatic rate but became evident in cases with invasion depth of T3-4. TDLN resection was at least as effective as dissection of other group-2 or -3 lymph nodes, including No. 112 nodes.
从转移率、对术后血液动力学的影响等因素来看,对于食管癌根治性食管切除术是否行胸段清扫术一直存在争议。本研究旨在探讨胸段清扫术是否有助于改善预后。
回顾性分析 1984 年至 2020 年间 1211 例行 D2/D3 解剖加胸段清扫术的胸段食管癌患者资料。定义沿胸段清扫的淋巴结为胸段内淋巴结(TDLN),其余第 112 组淋巴结为非胸段内淋巴结(非 TDLN)。比较 TDLN 和非 TDLN 的转移率及其预后,并与其他胸内淋巴结进行比较。同时分析与主病灶浸润深度的相关性(T0-2 期 545 例,T3-4 期 666 例)。
所有患者 TDLN/非 TDLN 的转移率分别为 7.3%/7.5%,T0-2 期为 2.2%/3.9%,T3-4 期为 11.5%/10.6%,均为晚期患者转移率较高。T3-4 期的淋巴结清扫效率指数(EI)为 TDLN 2.94,非 TDLN 3.44,差异无统计学意义。按肿瘤部位,TDLN 的转移率如下:Ut/Mt/Lt=1.1/2.4/2.4%(T0-2)和 7.7/14.5/8.4%(T3-4),Mt 区进展期患者转移率尤其高(~15%)。TDLN 与其他 2 组(Mt/Lt)和 3 组(Ut)区域淋巴结相比,EI 相当或更高,与部位无关。
T0-2 期转移率低,TD 切除意义不大,但 T3-4 期浸润深度时意义明显。TDLN 切除与包括第 112 组淋巴结在内的其他 2 组或 3 组淋巴结清扫效果相当。